Rezolute, Inc. — Director's Dealing 2022

Jun 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Rezolute, Inc. (RZLT)
CIK: 0001509261
Period of Report: 2022-06-23

Reporting Person: ROBERTS BRIAN KENNETH (Sr VP, Clinic Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-23	Stock Option (right to buy)	$3.40	A	700000	Acquired	2032-06-23	Common Stock (700000)	Direct

Footnotes

F1: This Option shall vest and become exercisable as follows: one fourth (1/4) of such Options shall vest on the one year anniversary of the Grant date and one thirty-sixth (1/36) of the remaining Options shall vest on the same day of each month thereafter until the Option is 100% vested. The unvested portion of the Option will not be exercisable on or after the Reporting Person's termination of Continuous Service.